Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CLCS Stock Summary
In the News
CLCS Financial details
Company Rating
Sell
Market Cap
22.74M
Income
-5.61M
Revenue
0
Book val./share
-0.42
Cash/share
0
Dividend
-
Dividend %
-
Employees
1
Optionable
No
Shortable
Yes
Earnings
23 Aug 2024
P/E
-2.93
Forward P/E
-
PEG
1.07
P/S
-
P/B
-1.02
P/C
-
P/FCF
-7.06
Quick Ratio
-
Current Ratio
0.02
Debt / Equity
-0.59
LT Debt / Equity
-
-
-
EPS (TTM)
-0.15
EPS next Y
-
EPS next Q
1.58
EPS this Y
-28.57%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
4.79%
-
-
-
-
SMA20
28.21%
SMA50
16.28%
SMA100
-18.03%
Inst Own
-
Inst Trans
-
ROA
-2258%
ROE
39%
ROC
0.27%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-21%
Shs Outstand
38.55M
Shs Float
24.64M
-
-
-
-
Target Price
-
52W Range
3.0E-4-0.74
52W High
-
52W Low
-
RSI
59.87
Rel Volume
0.29
Avg Volume
12.09K
Volume
3.51K
Perf Week
88.62%
Perf Month
45%
Perf Quarter
-
Perf Half Y
-14.71%
-
-
-
-
Beta
-151.061
-
-
Volatility
0.06%, 0.08%
Prev Close
16%
Price
0.58
Change
61.11%
CLCS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.08 | -0.17 | -0.19 | -0.21 | -0.15 | |
Operating cash flow per share | -0.07 | -0.09 | -0.1 | -0.1 | -0.09 | |
Free cash flow per share | -0.07 | -0.09 | -0.1 | -0.1 | -0.09 | |
Cash per share | 0 | 0 | 0.01 | 0 | 0.01 | |
Book value per share | -0.18 | -0.2 | -0.27 | -0.3 | -0.36 | |
Tangible book value per share | -0.18 | -0.2 | -0.27 | -0.3 | -0.36 | |
Share holders equity per share | -0.18 | -0.2 | -0.27 | -0.3 | -0.36 | |
Interest debt per share | 0.11 | 0.1 | 0.2 | 0.24 | 0.26 | |
Market cap | 20.61M | 31.16M | 58.2M | 42.39M | 29.61M | |
Enterprise value | 23.26M | 33.73M | 62.76M | 48.77M | 37.29M | |
P/E ratio | -9.73 | -6.51 | -10.59 | -6.2 | -5.73 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -10.29 | -12.04 | -20.97 | -12.55 | -9.43 | |
PFCF ratio | -10.29 | -12.04 | -20.97 | -12.55 | -9.43 | |
P/B Ratio | -4.19 | -5.43 | -7.32 | -4.31 | -2.34 | |
PTB ratio | -4.19 | -5.43 | -7.32 | -4.31 | -2.34 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -10.59 | -8.37 | -17.25 | -12.29 | -8.93 | |
EV to operating cash flow | -11.62 | -13.04 | -22.62 | -14.43 | -11.88 | |
EV to free cash flow | -11.62 | -13.04 | -22.62 | -14.43 | -11.88 | |
Earnings yield | -0.1 | -0.15 | -0.09 | -0.16 | -0.17 | |
Free cash flow yield | -0.1 | -0.08 | -0.05 | -0.08 | -0.11 | |
Debt to equity | -0.54 | -0.45 | -0.6 | -0.66 | -0.63 | |
Debt to assets | 40.63 | 22.64 | 10.62 | 20.62 | 19.29 | |
Net debt to EBITDA | -1.21 | -0.64 | -1.25 | -1.61 | -1.84 | |
Current ratio | 0.01 | 0.02 | 0.05 | 0.03 | 0.03 | |
Interest coverage | -4.19 | -12.36 | -3.88 | -2.95 | -4.21 | |
Income quality | 0.95 | 0.58 | 0.61 | 0.62 | 0.61 | |
Dividend Yield | 21.9K | 23.81K | 15.08K | 0 | 0 | |
Payout ratio | -213.13K | -155.11K | -159.66K | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.56 | 0.88 | 1.08 | 1.17 | 1.1 | |
ROIC | 1.09 | 1.29 | 1.4 | 1.49 | -169.53K | |
Return on tangible assets | -32.18 | -41.67 | -12.15 | -21.78 | -12.61 | |
Graham Net | -0.18 | -0.21 | -0.28 | -0.3 | -0.37 | |
Working capital | -4.92M | -5.6M | -7.95M | -9.83M | -12.63M | |
Tangible asset value | -4.92M | -5.74M | -7.95M | -9.83M | -12.63M | |
Net current asset value | -4.92M | -5.74M | -7.95M | -9.83M | -12.63M | |
Invested capital | -0.54 | -0.45 | -0.6 | -0.66 | -0.63 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 239.81K | 206.6K | 164.26K | 208.07K | 451.68K | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.43 | 0.83 | 0.69 | 0.7 | 0.41 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.04 | -0.04 | -0.05 | -0.03 | -0.04 | |
Operating cash flow per share | -0.03 | -0.02 | -0.01 | -0.03 | -0.01 | |
Free cash flow per share | -0.03 | -0.02 | -0.01 | -0.03 | -0.01 | |
Cash per share | 0 | 0.01 | 0 | 0 | 0 | |
Book value per share | -0.34 | -0.36 | -0.38 | -0.4 | -0.42 | |
Tangible book value per share | -0.34 | -0.36 | -0.38 | -0.4 | -0.42 | |
Share holders equity per share | -0.34 | -0.36 | -0.38 | -0.4 | -0.42 | |
Interest debt per share | 0.21 | 0.23 | 0.24 | 0.26 | 0.26 | |
Market cap | 84.58K | 29.61M | 15.56M | 26.05K | 22.92M | |
Enterprise value | 7.2M | 37.29M | 23.99M | 9.46M | 32.39M | |
P/E ratio | -0.02 | -5.54 | -2.3 | -0.01 | -4.28 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | -0.08 | -40.94 | -50.26 | -0.03 | -81.85 | |
PFCF ratio | -0.08 | -40.94 | -50.26 | -0.03 | -81.85 | |
P/B Ratio | -0.01 | -2.34 | -1.09 | 0 | -1.43 | |
PTB ratio | -0.01 | -2.34 | -1.09 | 0 | -1.43 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | -7.09 | -34.76 | -16.95 | -10.45 | -32.54 | |
EV to operating cash flow | -6.63 | -51.56 | -77.5 | -9.13 | -115.68 | |
EV to free cash flow | -6.63 | -51.56 | -77.5 | -9.13 | -115.68 | |
Earnings yield | -14.81 | -0.05 | -0.11 | -47.66 | -0.06 | |
Free cash flow yield | -12.85 | -0.02 | -0.02 | -39.77 | -0.01 | |
Debt to equity | -0.6 | -0.63 | -0.6 | -0.63 | -0.59 | |
Debt to assets | 19.92 | 19.29 | 36.86 | 26.1 | 38.15 | |
Net debt to EBITDA | -7.01 | -7.16 | -5.96 | -10.42 | -9.52 | |
Current ratio | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | |
Interest coverage | -4.3 | -4.06 | -5.13 | -2.4 | -2.9 | |
Income quality | 0.87 | 0.54 | 0.18 | 0.83 | 0.21 | |
Dividend Yield | 0 | 0.02 | 0.02 | 0 | 0.01 | |
Payout ratio | 0 | -0.43 | -0.18 | 0 | -0.22 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.52 | 0.56 | 0.63 | 0.55 | 0.58 | |
ROIC | 0.21 | 0.24 | 0.25 | 0.22 | 0.15 | |
Return on tangible assets | -3.47 | -3.26 | -7.28 | -3.43 | -5.39 | |
Graham Net | -0.35 | -0.37 | -0.39 | -0.41 | -0.43 | |
Working capital | -11.95M | -12.63M | -14.22M | -14.95M | -16.03M | |
Tangible asset value | -11.95M | -12.63M | -14.22M | -14.95M | -16.03M | |
Net current asset value | -11.95M | -12.63M | -14.22M | -14.95M | -16.03M | |
Invested capital | -0.6 | -0.63 | -0.6 | -0.63 | -0.59 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 528.11K | 677.27K | 933.76K | 1.06M | 1.25M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.1 | 0.11 | 0.12 | 0.08 | 0.08 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CLCS Frequently Asked Questions
What is Cell Source, Inc. stock symbol ?
Cell Source, Inc. is a US stock , located in New york of Ny and trading under the symbol CLCS
What is Cell Source, Inc. stock quote today ?
Cell Source, Inc. stock price is $0.58 today.
Is Cell Source, Inc. stock public?
Yes, Cell Source, Inc. is a publicly traded company.